Helix BioPharma Corp. Provides Update On The Timing Of Filing Of Third Quarter Results

NEXT STORY
Viela Bio Announces U.S. FDA Approval of UPLIZNA™ (inebilizumab-cdon) for the Treatment of Neuromyelitis Optica Spectrum Disorder (NMOSD)
PREV STORY
LHC Group promotes Joshua Proffitt to President and welcomes Robert Williams as new Chief Financial Officer
Subscribe now to PM360
Get in touch with PM360 Experts On Call

Experts on Call

Ads

You May Also Like

BeiGene Announces Pricing of $175 Million Public Offering

CAMBRIDGE, Mass. and BEIJING, China, Aug. 10, 2017 (GLOBE NEWSWIRE) -- BeiGene, Ltd. (NASDAQ:BGNE), ...

author_avatar
NASDAQ Market News

athenahealth and Tandigm Health Partner on Population Health Initiatives

WATERTOWN, Mass. and CONSHOHOCKEN, Pa., Oct. 20, 2016 (GLOBE NEWSWIRE) -- athenahealth, Inc. (NASDAQ:ATHN), ...

author_avatar
NASDAQ Market News

RAMSAY GENERALE DE SANTE : OPA CAPIO

PRESS RELEASE THIS PRESS RELEASE MAY NOT, DIRECTLY OR INDIRECTLY, BE DISTRIBUTED OR PUBLISHED ...

author_avatar
NASDAQ Market News